Total Payments
$5,288
2024 Payments
$1,240
Companies
27
Transactions
181
Medicare Patients
1,874
Medicare Billing
$147,252
Payment Breakdown by Category
Food & Beverage$3,909 (73.9%)
Travel$1,249 (23.6%)
Education$129.95 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,909 | 177 | 73.9% |
| Travel and Lodging | $1,249 | 2 | 23.6% |
| Education | $129.95 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Axonics, Inc. | $1,700 | 13 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $858.29 | 32 | $0 (2024) |
| Astellas Pharma US Inc | $422.41 | 19 | $0 (2022) |
| Janssen Biotech, Inc. | $407.58 | 24 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $352.88 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $287.48 | 10 | $0 (2024) |
| PFIZER INC. | $162.17 | 10 | $0 (2024) |
| ABBVIE INC. | $154.99 | 8 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $111.77 | 7 | $0 (2024) |
| UROVANT SCIENCES INC | $108.51 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,240 | 54 | Dendreon Pharmaceuticals LLC ($436.58) |
| 2023 | $953.75 | 45 | Dendreon Pharmaceuticals LLC ($222.03) |
| 2022 | $2,419 | 53 | Axonics, Inc. ($1,639) |
| 2021 | $674.58 | 29 | Astellas Pharma US Inc ($347.89) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Oncology | ||||||
| 11/13/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/08/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: UROLOGY | ||||||
| 09/12/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/12/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Diagnostic Imaging | ||||||
| 09/04/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $87.90 | General |
| Category: Oncology | ||||||
| 08/29/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/22/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: Oncology | ||||||
| 07/10/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Oncology | ||||||
| 07/03/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.28 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/14/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $23.57 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 490 | 784 | $221,663 | $58,181 |
| 2022 | 10 | 394 | 575 | $152,226 | $40,525 |
| 2021 | 16 | 512 | 556 | $94,114 | $25,113 |
| 2020 | 10 | 478 | 517 | $86,559 | $23,434 |
Total Patients
1,874
Total Services
2,432
Medicare Billing
$147,252
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 28 | 240 | $130,320 | $32,243 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 143 | 167 | $30,895 | $8,120 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 79 | $18,328 | $6,255 | 34.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 16 | 16 | $9,456 | $3,323 | 35.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 45 | 59 | $5,664 | $1,930 | 34.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $6,403 | $1,545 | 24.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 28 | $4,984 | $1,376 | 27.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 22 | 23 | $5,727 | $1,256 | 21.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 28 | 41 | $3,321 | $895.85 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,760 | $694.06 | 25.1% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 19 | 19 | $817.00 | $273.02 | 33.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 62 | 68 | $2,312 | $147.76 | 6.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 13 | $676.00 | $120.12 | 17.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 21 | 150 | $81,450 | $20,480 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 111 | $20,535 | $5,842 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 62 | $14,384 | $4,579 | 31.8% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2022 | 18 | 18 | $10,638 | $3,354 | 31.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 64 | $11,392 | $2,986 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $4,830 | $1,216 | 25.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 36 | 44 | $4,224 | $1,133 | 26.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 19 | 21 | $1,701 | $455.32 | 26.8% |
| 74018 | X-ray of abdomen, 1 view | Office | 2022 | 24 | 24 | $1,032 | $347.01 | 33.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 56 | 60 | $2,040 | $132.93 | 6.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 99 | 107 | $24,824 | $7,215 | 29.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 103 | $19,055 | $5,530 | 29.0% |
About Ashley Schneider, APRN
Ashley Schneider, APRN is a Acute Care healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2019. The National Provider Identifier (NPI) number assigned to this provider is 1972153401.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Schneider, APRN has received a total of $5,288 in payments from pharmaceutical and medical device companies, with $1,240 received in 2024. These payments were reported across 181 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,909).
As a Medicare-enrolled provider, Schneider has provided services to 1,874 Medicare beneficiaries, totaling 2,432 services with total Medicare billing of $147,252. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Other Specialties Acute Care
- Location Greenville, NC
- Active Since 09/17/2019
- Last Updated 01/12/2022
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1972153401
Products in Payments
- Axonics (Device) $1,663
- PROVENGE (Drug) $858.29
- ERLEADA (Drug) $371.35
- Nubeqa (Drug) $352.88
- XTANDI (Drug) $302.21
- GEMTESA (Drug) $207.11
- LYNPARZA (Biological) $181.26
- LUPRON DEPOT (Drug) $154.99
- KEYTRUDA (Biological) $106.22
- MYRBETRIQ (Drug) $77.90
- Xtandi (Drug) $74.52
- XIAFLEX (Biological) $73.88
- INTERSTIM (Device) $71.07
- PLUVICTO (Drug) $51.90
- AQUABEAM SYSTEM (Device) $46.59
- ORGOVYX (Drug) $45.98
- JELMYTO (Drug) $45.83
- BRAC CDx (Device) $43.89
- LYNPARZA (Drug) $41.50
- Axonics r-SNM System (Device) $37.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Greenville
Heather Bowers, Aprn, Agacnp-Bc, APRN, AGACNP-BC
Acute Care — Payments: $76,046
Acute Care $76,046
Benjamin Hocutt, Ag-Acnp, AG-ACNP
Acute Care — Payments: $17,029
Acute Care $17,029
Kathryn Rarick
Acute Care — Payments: $6,321
Acute Care $6,321
Lucretia Myers, Np, NP
Acute Care — Payments: $4,996
Acute Care $4,996
Mrs. Heather Day, Apn, APN
Acute Care — Payments: $4,363
Acute Care $4,363
Taylor Newton, Np, NP
Acute Care — Payments: $4,327
Acute Care $4,327